Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line

British Journal of Cancer

Volumn 87, Issue 11, 2002, Pages 1314-1320

  Barshishat, M ^a   Levi, I ^b   Benharroch, D ^b   Schwartz, B ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Butyrate; CD44; Colorectal cancer; Extracellular matrix; Metastasis

Indexed keywords

BUTYRIC ACID; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HERMES ANTIGEN; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DOWN REGULATION; EXTRACELLULAR MATRIX; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SITE DIRECTED MUTAGENESIS;

ANTIGENS, CD44; BUTYRATES; CARCINOMA; COLONIC NEOPLASMS; DNA PRIMERS; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; NEOPLASM METASTASIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0037132357     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600574     Document Type: Article

References (27)

1. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucl Acids Res 19: 2499
2. Archer SY, Meng S, Shai A, Hodin R (1998) P2IWAF1 is required for butyrate mediated growth inhibition of human colon cancer cells. Proc Natl Acad Sci USA 95: 6791-6796
3. Barshishat M, Polak-Charcon S, Schwartz B (2000) Butyrate regulates E-cadherin transcription, isoform expression and intracellular position in colon cancer cells. Br J Cancer 82: 195-203
4. Bresalier RS, Schwartz B, Kim YS, Du QH, Kleinman HK, Sullam PM (1995) The laminin-α1 chain Ile-Lys-Val-Ala-Val (IKVAV)- containing peptide promotes liver colonization by human colon cancer cells. Cancer Res 55: 2476-2480
5. Carey J (1991) Gel retardation. Methods Enzymol 208: 103-117
6. Gotley DC, Fawcett J, Walsh MD, Reeder JA, Simmons DL, Antalis TM (1996) Alternatively spliced variants of the cell adhesion molecule CD44 and tumour progression in colorectal cancer. Br J Cancer 74: 342-351
7. Gunther U, Hofmann M, Rudy W, Reber S, Zoller M, Haubmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65: 13-24
8. Hassing CA, Tong JK, Schriber SL (1997) Fiber-drived butyrate and the prevention of colon cancer. Crosstalk Chem Biol 4: 783-789
9. Harada N, Mizoi T, Kinouchi M, Hoshi K, Ishii S, Shiiba K, Sasaki I, Matsuno S (2001) Introduction of antisense CD44s cDNA down-regulates expression of overall CD44 isoforms and inhibits tumour growth and metastasis in highly metastatic colon carcinoma cells. Int J Cancer 91: 67-75
10. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W (1995) Progression of carcinoma cells is associated with alteration in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 11: 475-484
11. Herrera-Gayol A, Jothy S (1999) CD44 modulates Hs578T human breast cancer cell adhesion, migration and invasiveness. Exp Molec Pathol 66: 99-108
12. Katagiri YU, Slemman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H, Okumura K, Murakami M, Saiki I, Chambers AF, Uede T (1999) CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59: 219-226
13. Kaya G, Rodrigues I, Jorcano JL, Vassali P, Stamenkovic I (1997) Selective suppression of CD44 in keratinocytes of mice bearing an antisense CD44 transgene drived by a tissue-specific promoter disrupts hyaluronate metabolism in the skin and impairs keratinocyte proliferation. Genes Dev 11: 996-1007
14. Lester BR, MacCarthy JB (1992) Tumour cell adhesion to the extracellular matrix and signal transduction mechanisms implicated in tumour cell motility, invasion and metastasis. Cancer Met Rev 11: 31-44
15. Nakano K, Mizuno T, Sowa Y, Orita T, Yoshino T, Okuyama Y, Fujita T, Ohanti-Fujita N, Matsukawa Y, Tokino T, Yamagishi H, Oka T, Nomura H, Sakai Y (1997) Butyrate activates WAF1/Cip1 gene promoter through SP1 sites in a p53-negative human colon cancer cell line. J Biol Chem 272: 22199-22206
16. Pelizarro C, Coradini D, Daidone MG (2002) Modulation of angiogenesis-related proteins synthesis by sodium butyrate in colon cancer cell line HT29. Carcinogenesis 23: 735-740
17. Ponta H, Wainwright D, Herrlich P (1998) The CD44 protein family. Int J Biochem Cell Biol 30: 299-305
18. Reeder JA, Gotly DC, Walsh MD, Fawcett J, Antalis TM (1998) Expression of antisense CD44 variant 6 inhibits colorectal tumour metastasis and tumour growth in wound enviroment. Cancer Res 58: 3719-3726
19. Rudzki Z, Jothy S (1997) CD44 and the adhesion of neoplastic cells. J Clin Mol Pathol 50: 57-71
20. Schwartz B, Bresalier RS, Kim YS (1992) Role of mucin in cancer metastasis. Int J Cancer 52: 60-65
21. Schwartz B, Lamprecht SA, Polak-Charcon S, Niv Y, Kim YS (1995a) Induction of the differentiated phenotype in human colon cancer cells is associated with the attenuation of subcellular tyrosine phosphorylation. Oncol Res 7: 277-287
22. Schwartz B, Benharroch D, Prinsloo I, Cagnano E, Lamprecht SA (1995b) Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: An immunohistochemical analysis. Anticancer Res 15: 211-218
23. Schwartz B, Avivi-Green C, Polak-Charcon S (1998) Sodium butyrate induces retinoblastoma protein dephosphorylation, p16 expression and growth arrest of colon cancer cells. Mol Cell Biochem 188: 21-30
24. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternative spliced exons. Proc Natl Acad Sci USA 89: 12160-12164
25. Sherman L, Wainwright D, Ponta H, Herrlich P (1998) A splice variant of CD44 expressed in the apical ectoderm ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth. Genes Dev 12: 1058-1071
26. Shtivelman E, Bishop MJ (1991) Expression of CD44 is repressed in neurobastoma cells. Mol Cell Biol 11: 5446-5453
27. Zhang M, Wang MH, Singh RK, Wells A, Siegal GP (1997) Epidermal growth factor induces CD44 gene expression through a novel regulatory element in mouse fibroblasts. J Biol Chem 272: 14139-14146